#87 RANDOMIZED TRIAL COMPARING OUTPATIENT FLEXIBLE TO RIGID CYSTOSCOPY IN FEMALES

Presenter: Lieschen Quiroz

#88 Relationship between bacteriuria and ATP concentrations in voided urodynamic fluid: a 2-year prospective study.

Presenter: Ying Cheng

#89 Inhibition of Urothelial TRPA1 Channels Protects the Bladder Against Radiation Cystitis.

Presenter: Irina Zabbarova

#90 Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicenter, double-blind, randomised, placebo controlled study.

Presenter: Pierre Denys

#91 A Dose-Exploration Study Of The Efficacy and Safety Of OnabotulinumtoxinA in Patients With Urinary Incontinence Due To Neurogenic Detrusor Overactivity

Presenter: Apostolos Apostolidis

#92 Efficacy and tolerability of once-daily mirabegron, a potent and selective ß3-adrenoceptor agonist, in patients with overactive bladder – results from a North American Phase III trial

Presenter: Victor Nitti

#93 Safety and Potential Effectiveness of Cook MyoSite Autologous Muscle Derived Cells for Treatment of Stress Urinary Incontinence: Preliminary Results from a Dose Escalation Study

Presenter: Melissa Kaufman

#94 Brain activity underlying continence control in older women with urgency incontinence – a potential marker of functional status.

Presenter: Stasa Tadic

#95 The physiological properties of the decompensated, spinal cord injured bladder

Presenter: John Young

#96 An implantable pressure sensor to detect the onset of urinary bladder contractions

Presenter: Jacob Melgaard

#97 Evaluation of a novel, non-invasive, patient-managed neuromodulation system (PMNS) on urgency urinary incontinence and patient-reported outcomes in subjects with overactive bladder (OAB) syndrome who had previously failed therapy: a four-week, multicenter, prospective randomized trial

Presenter: Roger Dmochowski

#98 DUAL VAGINAL VAULT SUPPORT AT COLPORRHAPHY - AN ANATOMICAL BASIS FOR A FOUR-PART VAGINAL REPAIR

Presenter: Bernard Haylen